Company Overview
DENTSPLY SIRONA Inc. operates as a global manufacturer and marketer of dental equipment, cloud-enabled solutions, dental products, and healthcare consumable items specifically within the fields of urology and enterology. The company functions within the Healthcare sector, specifically the Medical Instruments & Supplies industry, which involves the production and distribution of specialized medical tools and disposable goods essential for clinical procedures. This entity employs approximately 14,000 staff members and holds a market capitalization of $2.31 billion, while generating total annual revenue of $3.68 billion. These valuation and revenue figures indicate that DENTSPLY SIRONA maintains a substantial operational footprint in the medical supply chain, positioning it as a significant player with a balance sheet large enough to support extensive manufacturing and distribution networks worldwide.
Financial Health
The company reported a trailing twelve-month revenue of $3.68 billion alongside a net income of -$598 million and an EBITDA of $597 million, revealing a significant disconnect where operational cash generation does not translate into bottom-line profit due to high cost structures or non-operating expenses. Despite the reported net loss, the firm generated positive free cash flow of $106.38 million, which provides a critical layer of financial flexibility for capital allocation, debt repayment, or strategic acquisitions without relying solely on external financing. Profitability analysis shows a gross margin of 50.0%, indicating efficient production relative to sales, contrasted by a low operating margin of 1.8% and a negative profit margin of -16.2%, suggesting that overhead costs and other expenses are consuming the majority of gross profits. The balance sheet presents a leveraged profile with $2.48 billion in debt against $354 million in cash, resulting in a debt-to-equity ratio of 185.00, which signals a capital structure heavily reliant on borrowed funds to finance operations. However, the current ratio stands at 1.51, indicating that the company holds sufficient current assets to cover its short-term liabilities with a comfortable safety margin. Return metrics further illustrate the financial landscape, with a return on equity of -36.4% reflecting the impact of losses on shareholder value, while a return on assets of 2.7% shows that the asset base is generating a nominal positive return before interest and tax considerations.
Valuation Assessment
Valuation metrics for DENTSPLY SIRONA Inc. present a complex picture, featuring a trailing P/E ratio of N/A due to the lack of earnings, while the forward P/E stands at 7.44, implying that the market is pricing in a significant turnaround in profitability over the coming year. The price-to-book ratio is recorded at 1.72, which suggests that the stock trades at a moderate premium over its book value, indicating that investors are willing to pay more than the net asset value per share. Alternative valuation measures include a price-to-sales ratio of 0.63 and an EV/EBITDA of 7.40, metrics that suggest the company is valued based on revenue and operational earnings rather than current net income, often a characteristic of firms undergoing restructuring or expecting future growth. Regarding price momentum, the stock has traded between a 52-week high of $17.18 and a 52-week low of $9.85, meaning the current share price sits at a level that reflects significant downside from the yearly peak but remains above the minimum support level. The stock exhibits a beta of 0.93, indicating that its price volatility is roughly in line with the broader market, suggesting it does not amplify or dampen market movements significantly during periods of volatility.
Growth & Income
Revenue growth for the trailing twelve months stands at 6.2%, while earnings growth is listed as N/A due to the reported net loss, indicating that top-line expansion is occurring without corresponding bottom-line improvement in the current period. The company currently offers a dividend yield of 5.0% with a payout ratio of 28.8%, a combination that suggests the dividend is being funded from cash flows or reserves rather than current net income, raising questions about long-term sustainability if earnings do not improve. Given the negative net income, the payout ratio of 28.8% is mathematically unsustainable based on current earnings per share, implying the dividend may be at risk or supported by cash reserves and free cash flow of $106.38 million. The overall profile combines modest revenue expansion with a high-yield but potentially fragile dividend payout, creating an income-focused opportunity that carries significant earnings risk given the -16.2% profit margin and -$598 million net income for the trailing twelve months.